| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RAPID COMMUNICATIONS |
Institute of Clinical Pharmacology (E.F., M.H., D.G., M.C., M.W.), Faculty of Clinical Medicine at Mannheim, University of Heidelberg, 68135 Mannheim, Germany, Clinic for Gynecology and Obstetrics (M.B., S.M.), Faculty of Clinical Medicine at Mannheim, University of Heidelberg (M.W.), School of Medicine, University of California, Davis, California 95616
Address all correspondence and requests for reprints to: M. Wehling, Institute of Clinical Pharmacology, Faculty of Clinical Medicine at Mannheim, University of Heidelberg, 68135 Mannheim, Germany.
Abstract
Rapid, nongenomic effects of steroids are supposed to be transmitted by membrane receptors unrelated to the classic intracellular steroid receptors. In this context, a putative progesterone membrane binding protein (mPR) has been identified, recently. Here we show that expression of mPR-cDNA in CHO cells leads to increased microsomal progesterone binding. This result is mirrored by effects of an antibody raised against the recombinant E. coli mPR which suppressed the rapid progesterone-initiated Ca2+ increase in sperm. Our results support the assumption that mPR represents the first steroid membrane receptor or a part of it involved in rapid, nongenomic steroid signalling.
This article has been cited by other articles:
![]() |
C Dosiou, A E Hamilton, Y Pang, M T Overgaard, S Tulac, J Dong, P Thomas, and L C Giudice Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone J. Endocrinol., January 1, 2008; 196(1): 67 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hanna, Y. Pang, P. Thomas, and Y. Zhu Cell-surface expression, progestin binding, and rapid nongenomic signaling of zebrafish membrane progestin receptors {alpha} and {beta} in transfected cells. J. Endocrinol., August 1, 2006; 190(2): 247 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Price, E. L. Hansen, and T. N. Oliver Immunofluorescent Localization of a Novel Progesterone Receptor(s) in a T47D-Y Breast Cancer Cell Line Lacking Genomic Progesterone Receptor Expression Reproductive Sciences, December 1, 2005; 12(8): 610 - 616. [Abstract] [PDF] |
||||
![]() |
Z. Cai and C. Stocco Expression and Regulation of Progestin Membrane Receptors in the Rat Corpus Luteum Endocrinology, December 1, 2005; 146(12): 5522 - 5532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Jang and L S H Yi Identification of a 71 kDa protein as a putative non-genomic membrane progesterone receptor in boar spermatozoa J. Endocrinol., February 1, 2005; 184(2): 417 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hatzoglou, M. Kampa, C. Kogia, I. Charalampopoulos, P. A. Theodoropoulos, P. Anezinis, C. Dambaki, E. A. Papakonstanti, E. N. Stathopoulos, C. Stournaras, et al. Membrane Androgen Receptor Activation Induces Apoptotic Regression of Human Prostate Cancer Cells in Vitro and in Vivo J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 893 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Boldyreff and M. Wehling Aldosterone: Refreshing a Slow Hormone by Swift Action Physiology, June 1, 2004; 19(3): 97 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Hammes The further redefining of steroid-mediated signaling PNAS, March 4, 2003; 100(5): 2168 - 2170. [Full Text] [PDF] |
||||
![]() |
Y. Zhu, J. Bond, and P. Thomas Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor PNAS, March 4, 2003; 100(5): 2237 - 2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Haynes, L. Li, D. Sinha, K. S. Russell, K. Hisamoto, R. Baron, M. Collinge, W. C. Sessa, and J. R. Bender Src Kinase Mediates Phosphatidylinositol 3-Kinase/Akt-dependent Rapid Endothelial Nitric-oxide Synthase Activation by Estrogen J. Biol. Chem., January 17, 2003; 278(4): 2118 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. B. Cato, A. Nestl, and S. Mink Rapid Actions of Steroid Receptors in Cellular Signaling Pathways Sci. Signal., June 25, 2002; 2002(138): re9 - re9. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Filardo, J. A. Quinn, A. R. Frackelton Jr., and K. I. Bland Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis Mol. Endocrinol., January 1, 2002; 16(1): 70 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Haynes, D. Sinha, K. S. Russell, M. Collinge, D. Fulton, M. Morales-Ruiz, W. C. Sessa, and J. R. Bender Membrane Estrogen Receptor Engagement Activates Endothelial Nitric Oxide Synthase via the PI3-Kinase-Akt Pathway in Human Endothelial Cells Circ. Res., October 13, 2000; 87(8): 677 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nadal, A. B. Ropero, O. Laribi, M. Maillet, E. Fuentes, and B. Soria Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta PNAS, October 10, 2000; 97(21): 11603 - 11608. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Filardo, J. A. Quinn, K. I. Bland, and A. R. Frackelton Jr. Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF Mol. Endocrinol., October 1, 2000; 14(10): 1649 - 1660. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |